Cascade filtration for TTP: an effective alternative to plasma exchange with cryodepleted plasma

Transfusion Science - Tập 21 - Trang 193-199 - 1999
R. Bruni1, G. Giannini1, G. Lercari1, A. Bo1, G. Florio1, M.C. De Luigi1, A. Marmont1, A. Gobbi1, E. Damasio1, M. Valbonesi1
1Immunohematology Service and Department of Hematology, San Martino University Hospital, Largo R. Benzi 10, 16132 Genova, Italy

Tài liệu tham khảo

Moake, 1994, Solvent/detergent treated plasma suppresses shear-induced platelet agggregation and prevents episodes of thrombotic thrombocytopenic purpura, Blood, 84, 490, 10.1182/blood.V84.2.490.490 Moake, 1989, Abnormalities of Von Willebrand factor in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome, Am J Med, 87, 3 Furlan, 1998, Von Willebrand factor – cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome, N Engl J Me, 339, 1578, 10.1056/NEJM199811263392202 Tsai, 1998, Antibodies to Von Willebrand factor – cleaving protease in acute thrombotic thrombocytopenic purpura, N Engl J Med, 339, 1585, 10.1056/NEJM199811263392203 Moake, 1985, Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine, Am J Haematol, 20, 73, 10.1002/ajh.2830200110 Bobbio-Pallavicini, 1994, Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma exchange, Eur J Haematol, 52, 222, 10.1111/j.1600-0609.1994.tb00649.x Hoffkes, 1995, Recovery by splenectomy in patients with relapsed thrombotic thrombocytopenic purpura and treatment failure to plasma exchange, Semin Thromb Hemost, 21, 161, 10.1055/s-2007-1000391 Musso M, Porretto F, Crescimanno A, et al. Trapianto autologo di cellule staminali periferiche nel trattamento delle malattie autoimmuni-Indicazioni cliniche- IX Congr. SIDE, Cagliari, 25–28 May 1999 [abstract book] Bayik, 1993, Treatment of thrombotic thrombocytopenic purpura with defibrotide, Am J Haematol, 43, 74, 10.1002/ajh.2830430120 Creager, 1198, Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infection – transfusion, 38, 419 Watson, 1989, Cis-platinum associated hemolytic-uremic syndrome. Successful treatment with a Staphylococcal protein A column, Cancer, 64, 1400, 10.1002/1097-0142(19891001)64:7<1400::AID-CNCR2820640705>3.0.CO;2-N Valbonesi M, Florio G, Frisoni R, et al. Cascade filtration (CF) in the management of TTP. In: Fifth WAA Congress, WAA (Ed.). 1994 9–12 Mar: Houston, p. 63 [abstract book] Valbonesi, 1987, Cascade filtration with reverse rinse of the secondary filter, J Clin Apheresis, 3, 240, 10.1002/jca.2920030410 Ramanan, 1999, Thrombotic thrombocytopenic purpura: a single institution experience, J Clin Apheresis, 14, 9, 10.1002/(SICI)1098-1101(1999)14:1<9::AID-JCA2>3.0.CO;2-3 Valbonesi, 1988, Thrombotic microangiopathy of the miscellaneous secondary type responding to plasma exchange in a liver transplant recipient, Int J Artif Organs, 11, 131, 10.1177/039139888801100214 Chin, 1997, Treatment of thrombotic thrombocytopenic purpura with intravenous gammaglobulin, Transfusion, 27, 115, 10.1046/j.1537-2995.1987.27187121458.x Popovsky, 1998, A 49-year-old woman with thrombotic thrombocytopenic purpura and severe dyspnea during plasmapheresis and transfusion, N Engl J Med, 339, 2005, 10.1056/NEJM199812313392708 Bandarenko N, Bucher ME, Members of the US TTP Apheresis Study Group: United States thrombotic thrombocytopenic purpura Apheresis Study Group (US TTP ASG). Multicenter study and retrospective analysis of current efficacy of therapeutic plasma Exchange. J Clin Apheresis 1998;13:133–141